Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

order inexpensively medications without prescription

Read More »

obtain inexpensively generic pills online

Read More »

purchase a cheap medications no prescription

Read More »

obtain at an easy rate medications without a doctor

Read More »

Booming Cincinnati CRO Medpace Plans to Hire 650 New Employees

Two months after going public, Medpace Holdings Inc. has big expansion plans that call for the hiring of 650 additional employees and retain more than 1,150 positions, the Cincinnati Business Courier reported.

Read More »

In 3Q Report, Shire Breaks Out Data From Baxalta Acquisition and Announces Several Program Terminations

Third-quarter financial reports show how companies are doing going into the end of the year. And this year, at least, they show a number of biopharma companies killing programs. Shire reported that it was terminating its SHP610 program for Sanfilippo A after a failed Phase IIb study.

Read More »

Pfizer Abandons Cholesterol Drug Bococizumab

Pfizer has abandoned its PCSK9 inhibitor program to treat cholesterol. The company is ending its global development of all bococizumab SPIRE Phase III trials.

Read More »

Former Valeant CEO and CFO May Face Criminal Charges

Although they have both been out from their executive leadership roles at embattled Valeant Pharmaceuticals, J. Michael Pearson and Howard Schiller’s troubles are not over. Both men may be facing a criminal investigation probe by U.S. prosecutors, according to news reports.

Read More »

Novartis breast cancer drug gets FDA fast track

The U.S. FDA gave fast-track review status to Novartis’ medication ribociclib in first-line treatment of postmenopausal women with advanced breast cancer.

Read More »

MAHF names Ryan Abbate, Mike Lazur 2017 Inductees

The membership of the Medical Advertising Hall of Fame has elected its 2017 inductees: Ryan Abbate, innovator and founder of Pacific Communications, and Mike Lazur, award-winner creative director of Torre Lazur.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom